Document is current
Any future updates will be listed below
-
Authors
Liu, Yang
Hill, Holly A.
Li, Yijing
McIntosh, Joseph
Jiang, Vivian
Yan, Fangfang
Yao, Yixin
Fei, Yue
Zhang, Jared
Qu, Lawrence
Yao, Jun
Jain, Preetesh
Chen, Ken
Wang, Michael
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 9 October 2025
First Online: 21 November 2025
Competing interests
: M.W. is consultant to AbbVie, Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Deciphera, InnoCare, Janssen, Kite Pharma, Leukemia & Lymphoma Society, Lilly, Merck, Milken Institute, Oncternal, Parexel, Pepromene Bio, Pharmacyclics, and VelosBio, and he has received research support from Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Celgene, Genmab, Genentech, Innocare, Janssen, Juno Therapeutics, Kite Pharma, Lilly, Loxo Oncology, Molecular Templates, Oncternal, Pharmacyclics, VelosBio, Vincerx. M.W. also received a speaker honorarium from AbbVie, Acerta Pharma, AstraZeneca, BeiGene, BioInvent, Dava Oncology, Eastern Virginia Medical School, IDEOlogy Health, Janssen, Kite Pharma, Leukemia & Lymphoma Society, LLC TS Oncology, Medscape, Meeting Minds Experts, MJH Life Sciences, Merck, Moffit Cancer Center, Oncology Specialty Group, OncLive, Pharmacyclics, Physicians Education Resources (PER), Practice Point Communications (PPC), and Studio ER Congressi. The remaining authors have no conflicts of interest to declare.
